INVX
Innovex International, Inc.Company with tickers: INVX
CIK
1042893
CUSIP
457651107
Shares Outstanding
68,759,676
13F Activity (30d)
128 filings
123 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $239,031,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Cost of Revenue | $154,522,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-21,832,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-16,671,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-0.24 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-0.24 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |